-
Sign up for our new free newsletters for industry news, insight, and analysis: https://mailchi.mp/xconomy.com/subscribe-twitter-profile …
#Xconomists#XconXpertise#XconBioRoundup#XcelerateLS#XconSD#XconSF#XconNY#XconBOS#XconSEA#XconPHIpic.twitter.com/BW5Oav6cRA
-
Insight from experts such as
@BlackThornRX,@eperlste/@ReeveFoundation, Alector,@CIRMnews,@aiforia_tech & more: https://xconomy.com/xpertise/whats-next-neuroscience-therapies/ …#XconSF pic.twitter.com/ww7EqQ9z5R
-
Did you attend
@Xconomy: What’s Next in Neuroscience Therapies? Our CMO Jane Tiller MD and Kristina Burow of ARCH Venture Partners presented our approach leveraging computational and clinical neuroscience to develop targeted therapeutics for CNS disorders.#XconSF#Neurosciencepic.twitter.com/X0U6uYPgJu
-
See you tomorrow! Explore new tech changing how we understand brain diseases/spinal injuries & novel approaches companies are taking to treat these conditions: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum/ …
#XconSF pic.twitter.com/E55uOt2OLD
-
At
@Xconomy’s What’s Next in Neuroscience, engage with scientists, entrepreneurs & other biotech leaders developing next-gen therapies/tech in spinal-cord injuries, mental health, addiction, dementia, Alzheimer's & more. Nov 19 in San Francisco: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum …#XconSF pic.twitter.com/PCjHGV7AX1
-
Join us tomorrow to explore new tech changing how we understand brain diseases/spinal injuries, as well as novel approaches companies are taking to treat these conditions. Featuring
@BlackThornRX,@eperlste/@ReeveFoundation, Alector,@CIRMnews: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum/ …#XconSF pic.twitter.com/YFewG1ZDtP
-
Last chance for discount tickets! Prices go up tonight at midnight. Explore new tech changing how we understand brain diseases/spinal injuries & novel approaches companies are taking to treat these conditions: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum …
#XconSF pic.twitter.com/jApPDSs9SJ
-
Ticket sale ends tomorrow! Engage with scientists, entrepreneurs & other biotech leaders developing next-gen therapies/tech in spinal-cord injuries, mental health, addiction, dementia, Alzheimer's & more: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum …
#XconSF pic.twitter.com/MP07ixYpPa
-
Join us next week to explore new tech changing how we understand brain diseases/spinal injuries, as well as novel approaches companies are taking to treat these conditions. Feauring
@BlackThornRX,@eperlste/@ReeveFoundation, Alector,@CIRMnews: https://xconomy.com/san-francisco/2019/11/11/neuroscience-is-taking-the-spotlight-at-xconomys-bay-area-xchange/ …#XconSF -
Brain disorders are among the toughest to diagnose/treat, but new approaches/tech could change everything. Join
@Xconomy,@BlackThornRX,@eperlste/@ReeveFoundation, Alector,@CIRMnews & more for What’s Next in Neuroscience - 11/19 in San Francisco: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum …#XconSF pic.twitter.com/jDII8kvS2R
-
Brain disorders are among the toughest to diagnose/treat, but new approaches/tech could change everything. Join
@BlackThornRX,@eperlste/@ReeveFoundation, Alector,@CIRMnews & more next week. Ticket prices go up after Friday: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum …#XconSF pic.twitter.com/FPjnHMnE16
-
Neuroscience Is Taking the Spotlight at Xconomy’s Bay Area Xchange https://xconomy.com/san-francisco/2019/11/11/neuroscience-is-taking-the-spotlight-at-xconomys-bay-area-xchange/ …
#xconSF -
At What’s Next in Neuroscience, engage with scientists, entrepreneurs & other biotech leaders developing next-gen therapies/tech in spinal-cord injuries, mental health, addiction, dementia, Alzheimer's & more. Nov 19 in San Francisco: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum …
#XconSF pic.twitter.com/2vuo4nswBJ
-
Brain disorders are among the toughest to diagnose/treat, but new approaches/tech could change everything. Join
@BlackThornRX,@eperlste/@ReeveFoundation, Alector,@CIRMnews & more: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum …#XconSF pic.twitter.com/tYwp3kzqxM
-
Brain disorders are among the toughest to diagnose/treat, but new approaches/tech could change everything. Join
@BlackThornRX,@eperlste/@ReeveFoundation, Alector,@CIRMnews & more for What’s Next in Neuroscience - 11/19 in San Francisco: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum …#XconSF pic.twitter.com/N4xHgRGp0h
-
At What’s Next in Neuroscience, engage with scientists, entrepreneurs & biotech execs developing next-gen therapies/tech in spinal-cord injuries, precision mental health, addiction, dementia, Alzheimer's & more. Nov 19 in San Francisco: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum …
#XconSF pic.twitter.com/Ozpo7E7qMk
-
At
@Xconomy’s What’s Next in Neuroscience, engage with scientists, entrepreneurs & biotech execs developing next-gen therapies/tech in spinal-cord injuries, precision mental health, addiction, dementia, Alzheimer's & more. Nov 19 in San Francisco: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum …#XconSF pic.twitter.com/JkvJ1J5veF
-
Brain disorders are among the toughest to diagnose/treat, but new approaches/tech could change everything. Join
@Xconomy,@BlackThornRX,@eperlste/@ReeveFoundation, Alector,@CIRMnews & more for What’s Next in Neuroscience - 11/19 in San Francisco: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum …#XconSF pic.twitter.com/C0gqV5Tc05
-
Ticket price goes up tonight! Engage with scientists, entrepreneurs & biotech executives developing next-gen neuroscience therapies and tech in areas such as spinal-cord injuries, precision mental health, addiction, dementia, Alzheimer's: https://xconomy.com/whats-next-neuroscience-therapies-life-science-forum/ …
#XconSF pic.twitter.com/gGhKT2peFd
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.